Literature DB >> 33446419

Study of the predictors for radiation pneumonitis in patient with non-small cell lung cancer received radiotherapy after pneumonectomy.

J-H Yu1, C-L Wang2, Y Liu3, J-M Wang2, C X Lv2, J Liu2, Q Zhang2, X-L Fu2, X-W Cai4.   

Abstract

PURPOSE: To identify the valuable predictors of grade≥2 radiation pneumonitis (RP) in patient treated with radiotherapy after pneumonectomy for non-small cell lung cancer (NSCLC); and to construct a nomogram predicting the incidence of grade≥2 RP in such patients. PATIENTS AND METHODS: We reviewed 82 patients with NSCLC received radiotherapy after pneumonectomy from 2008 to 2018. The endpoint was grade≥2 RP. Univariate and multivariate regression analysis were conducted to evaluate significant factors of grade≥2 RP. Receiver operating characteristic (ROC) curve was used to establish optimal cutoff values and the nomogram was built to make the predictive model visualized. Descriptive analysis was performed on 5 patients with grade 3 RP.
RESULTS: A total of 22(26.8%) patients developed grade 2 RP and 5(6.1%) patients were grade 3 RP. V5, V10, V20, V30, MLD, PTV, and PTV/TLV were associated with the occurrence of grade≥2 RP in univariate analysis, while none of the clinical factors was significant; V5(OR,1.213;95%CI,1.099-1.339; P<0.001) and V20(OR,1.435;95%CI,1.166-1.765; P=0.001) were the independent significant predictors by multivariate analysis and were included in the nomogram. The ROC analysis for the cutoff values for predicting grade≥2 RP were V5>23% (AUC=0.819, sensitivity:0.701, specificity:0.832) and V20>8% (AUC=0.812, sensitivity:0.683, specificity:0.811). Additionally, grade≥3 RP did not occur when V5<30%, V20<13% and MLD<751.2cGy, respectively.
CONCLUSIONS: Our study showed that V5 and V20 were independent predictors for grade≥2 RP in NSCLC patients receiving radiotherapy after pneumonectomy. Grade 3 RP did not occur whenV5<30%, V20<13% and MLD<751.2cGy, respectively. In addition, patient underwent right pneumonectomy may have a lower tolerance to radiation compared to left pneumonectomy.
Copyright © 2020 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer du poumon non à petites cellules; Dose-volume histograms; Histogrammes dose-volume; Non-small cell lung cancer; Pneumonectomie; Pneumonectomy; Pneumonite par irradiation; Radiation pneumonitis

Year:  2021        PMID: 33446419     DOI: 10.1016/j.canrad.2020.11.001

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  3 in total

1.  Serum MMP-9 and SAA in the Diagnosis of Severe Pneumonia Caused by Radiotherapy of Esophageal Cancer.

Authors:  Yu Zhou; Li Liu; Wenjun Gu
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-05       Impact factor: 2.629

2.  Risk factors for radiation pneumonitis after rotating gantry intensity-modulated radiation therapy for lung cancer.

Authors:  Saori Tatsuno; Hiroshi Doi; Wataru Okada; Eri Inoue; Kiyoshi Nakamatsu; Masao Tanooka; Masahiro Tanaka; Yasumasa Nishimura
Journal:  Sci Rep       Date:  2022-01-12       Impact factor: 4.379

Review 3.  Research Progress on Radiotherapy Combined with Immunotherapy for Associated Pneumonitis During Treatment of Non-Small Cell Lung Cancer.

Authors:  Anqi Zhang; Fuyuan Yang; Lei Gao; Xiaoyan Shi; Jiyuan Yang
Journal:  Cancer Manag Res       Date:  2022-08-13       Impact factor: 3.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.